Patents by Inventor Karen Ann Delahay

Karen Ann Delahay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ALBUMIN VARIANTS AND CONJUGATES
    Publication number: 20230039076
    Abstract: The present invention relates to conjugation-competent albumins and albumin-related polypeptides, and their conjugates with at least one moiety, and to polynucleotides encoding them.
    Type: Application
    Filed: March 28, 2022
    Publication date: February 9, 2023
    Inventors: Karen Ann Delahay, Christopher John Arthur Finnis, Karl Michael Nicholls
  • ALBUMIN VARIANTS AND CONJUGATES
    Publication number: 20210070839
    Abstract: The present invention relates to conjugation-competent albumins and albumin-related polypeptides, and their conjugates with at least one moiety, and to polynucleotides encoding them.
    Type: Application
    Filed: March 16, 2020
    Publication date: March 11, 2021
    Inventors: Karen Ann Delahay, Christopher John Arthur Finnis, Karl Michael Nicholls
  • Albumin variants
    Patent number: 10934341
    Abstract: The present invention relates to variants of a parent albumin, the variants having altered plasma half-life compared with the parent albumin. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: March 2, 2021
    Assignee: ALBUMEDIX, LTD.
    Inventors: Jason Cameron, Karen Ann Delahay, Jens Erik Nielsen, Andrew Plumridge, Jan Terje Andersen
  • Albumin variants and conjugates
    Patent number: 10633428
    Abstract: The present invention relates to conjugation-competent albumins and albumin-related polypeptides, and their conjugates with at least one moiety, and to polynucleotides encoding them.
    Type: Grant
    Filed: August 19, 2016
    Date of Patent: April 28, 2020
    Assignee: ALBUMEDIX LTD
    Inventors: Karen Ann Delahay, Christopher John Arthur Finnis, Karl Michael Nicholls
  • ALBUMIN VARIANTS
    Publication number: 20200102367
    Abstract: The present invention relates to variants of a parent albumin, the variants having altered plasma half-life compared with the parent albumin. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: October 10, 2019
    Publication date: April 2, 2020
    Inventors: Jason Cameron, Karen Ann Delahay, Jens Erik Nielsen, Andrew Plumridge, Jan Terje Andersen
  • ALBUMIN VARIANTS
    Publication number: 20200102368
    Abstract: The invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The invention also relates to fusion polypeptides and conjugates comprising said variant albumin.
    Type: Application
    Filed: October 22, 2019
    Publication date: April 2, 2020
    Inventors: Jan Terje Andersen, Bjorn Dalhus, Inger Sandlie, Jason Cameron, Andrew Plumridge, Esben Peter Friis, Karen Ann Delahay
  • Albumin variants
    Patent number: 10501524
    Abstract: The present invention relates to variants of a parent albumin, the variants having altered plasma half-life compared with the parent albumin. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: April 13, 2015
    Date of Patent: December 10, 2019
    Assignee: ALBUMEDIX LTD
    Inventors: Jason Cameron, Karen Ann Delahay, Jens Erik Nielsen, Andrew Plumridge, Jan Terje Andersen
  • ALBUMIN VARIANTS
    Publication number: 20190315836
    Abstract: The present invention relates to variants of a parent albumin, the variants having altered plasma half-life compared with the parent albumin. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: May 6, 2019
    Publication date: October 17, 2019
    Inventor: Karen Ann Delahay
  • Albumin variants
    Patent number: 10329340
    Abstract: The present invention relates to variants of a parent albumin, the variants having altered plasma half-life compared with the parent albumin. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: March 8, 2018
    Date of Patent: June 25, 2019
    Assignee: ALBUMEDIX LTD
    Inventor: Karen Ann Delahay
  • ALBUMIN VARIANTS AND CONJUGATES
    Publication number: 20180265568
    Abstract: The present invention relates to conjugation-competent albumins and albumin-related polypeptides, and their conjugates with at least one moiety, and to polynucleotides encoding them.
    Type: Application
    Filed: August 19, 2016
    Publication date: September 20, 2018
    Inventors: Karen Ann Delahay, Christopher John Arthur Finnis, Karl Michael Nicholls
  • ALBUMIN VARIANTS
    Publication number: 20180265569
    Abstract: The present invention relates to variants of a parent albumin, the variants having altered plasma half-life compared with the parent albumin. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: March 8, 2018
    Publication date: September 20, 2018
    Inventor: Karen Ann Delahay
  • Albumin variants
    Patent number: 9944691
    Abstract: The present invention relates to variants of a parent albumin, the variants having altered plasma half-life compared with the parent albumin. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: April 17, 2018
    Assignee: Albumedix A/S
    Inventor: Karen Ann Delahay
  • ALBUMIN VARIANTS
    Publication number: 20150210752
    Abstract: The present invention relates to variants of a parent albumin, the variants having altered plasma half-life compared with the parent albumin. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: April 13, 2015
    Publication date: July 30, 2015
    Inventors: Jason Cameron, Karen Ann Delahay, Jens Erik Nielsen, Andrew Plumridge, Jan Terje Andersen
  • ALBUMIN VARIANTS
    Publication number: 20150065687
    Abstract: The present invention relates to variants of a parent albumin, the variants having altered plasma half-life compared with the parent albumin. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: March 15, 2013
    Publication date: March 5, 2015
    Inventor: Karen Ann Delahay
  • ALBUMIN VARIANTS
    Publication number: 20140128326
    Abstract: The present invention relates to variants of a parent albumin, the variants having altered plasma half-life compared with the parent albumin. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: November 8, 2013
    Publication date: May 8, 2014
    Applicants: Novozymes Biopharma DK A/S, University of OSLO, Novozymes Biopharma UK Limited, Novozymes A/S
    Inventors: Jason Cameron, Karen Ann Delahay, Jens Erik Nielsen, Andrew Plumridge, Jan Terje Andersen